These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9032000)

  • 1. Refining treatment approaches in obsessive-compulsive disorder.
    Fineberg N
    Int Clin Psychopharmacol; 1996 Dec; 11 Suppl 5():13-22. PubMed ID: 9032000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.
    Dell'Osso B; Nestadt G; Allen A; Hollander E
    J Clin Psychiatry; 2006 Apr; 67(4):600-10. PubMed ID: 16669725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic therapy of obsessive compulsive disorder.
    DeVeaugh-Geiss J
    Adv Pharmacol; 1994; 30():35-52. PubMed ID: 7833296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SSRIs in the treatment of obsessive-compulsive disorder.
    Cartwright C; Hollander E
    Depress Anxiety; 1998; 8 Suppl 1():105-13. PubMed ID: 9809222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
    Todorov C; Freeston MH; Borgeat F
    Can J Psychiatry; 2000 Apr; 45(3):257-62. PubMed ID: 10779882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of serotonergic drugs: focus on OCD.
    Marazziti D; Avella MT; Basile L; Mucci F; Dell'Osso L
    Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):261-273. PubMed ID: 30793987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine for obsessive-compulsive disorder: prescribing guidelines.
    James WA; Lippmann SB
    South Med J; 1991 Oct; 84(10):1243-5. PubMed ID: 1925726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA; Fineberg NA; Montgomery D
    Encephale; 1990; 16 Spec No():335-9. PubMed ID: 2209492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OCD: where the serotonin selectivity story begins.
    Pigott TA
    J Clin Psychiatry; 1996; 57 Suppl 6():11-20. PubMed ID: 8647793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clomipramine and obsessive-compulsive disorder.
    Scahill L; Lynch KA
    J Child Adolesc Psychiatr Nurs; 1995; 8(2):42-5. PubMed ID: 7795952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current concepts in the pharmacological treatment of obsessive-compulsive disorder.
    Zohar J; Zohar-Kadouch RC; Kindler S
    Drugs; 1992 Feb; 43(2):210-8. PubMed ID: 1372219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological treatments for obsessive-compulsive disorder and the serotonin-dopamine hypothesis].
    Okamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(1):36-44. PubMed ID: 21404630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pharmacological Treatment of Obsessive-Compulsive Disorder.
    Pittenger C
    Psychiatr Clin North Am; 2023 Mar; 46(1):107-119. PubMed ID: 36740347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment of obsessive-compulsive disorder.
    Zohar J; Insel TR
    J Affect Disord; 1987; 13(2):193-202. PubMed ID: 2960711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.